| The metabolism of phosphoinositide-derived messenger molecules PW Majerus, TM Connolly, H Deckmyn, TS Ross, TE Bross, H Ishii, ... Science 234 (4783), 1519-1526, 1986 | 880 | 1986 |
| Platelets at work in primary hemostasis K Broos, HB Feys, SF De Meyer, K Vanhoorelbeke, H Deckmyn Blood reviews 25 (4), 155-167, 2011 | 652 | 2011 |
| Platelet actuation D Blockmans, H Deckmyn, J Vermylen Blood reviews 9 (3), 143-156, 1995 | 419 | 1995 |
| Neutrophil extracellular traps in ischemic stroke thrombi E Laridan, F Denorme, L Desender, O Francois, T Andersson, H Deckmyn, ... Annals of neurology 82 (2), 223-232, 2017 | 416 | 2017 |
| Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood PRM Siljander, ICA Munnix, PA Smethurst, H Deckmyn, T Lindhout, ... Blood 103 (4), 1333-1341, 2004 | 272 | 2004 |
| The hemostatic system JM Stassen, J Arnout, H Deckmyn Current medicinal chemistry 11 (17), 2245-2260, 2004 | 268 | 2004 |
| Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients Y Vanrenterghem, T Lerut, L Roels, J Gruwez, P Michielsen, ... The Lancet 325 (8436), 999-1002, 1985 | 259 | 1985 |
| MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man. K Peerlinck, I De Lepeleire, M Goldberg, D Farrell, J Barrett, E Hand, ... Circulation 88 (4), 1512-1517, 1993 | 250 | 1993 |
| Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. H Matsuno, JM Stassen, J Vermylen, H Deckmyn Circulation 90 (5), 2203-2206, 1994 | 241 | 1994 |
| von Willebrand factor to the rescue SF De Meyer, H Deckmyn, K Vanhoorelbeke Blood, The Journal of the American Society of Hematology 113 (21), 5049-5057, 2009 | 212 | 2009 |
| Platelet adhesion to collagen BP Nuyttens, T Thijs, H Deckmyn, K Broos Thrombosis research 127, S26-S29, 2011 | 211 | 2011 |
| Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance S Staessens, F Denorme, O Francois, L Desender, T Dewaele, ... Haematologica 105 (2), 498, 2020 | 200 | 2020 |
| Matrix-specific suppression of integrin activation in shear stress signaling AW Orr, MH Ginsberg, SJ Shattil, H Deckmyn, MA Schwartz Molecular biology of the cell 17 (11), 4686-4697, 2006 | 200 | 2006 |
| Deficiency of von Willebrand factor protects mice from ischemic stroke C Kleinschnitz, SF De Meyer, T Schwarz, M Austinat, K Vanhoorelbeke, ... Blood, The Journal of the American Society of Hematology 113 (15), 3600-3603, 2009 | 196 | 2009 |
| ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis HB Feys, MT Canciani, F Peyvandi, H Deckmyn, K Vanhoorelbeke, ... British journal of haematology 138 (4), 534-540, 2007 | 189 | 2007 |
| A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2 G Defreyn, H Deckmyn, J Vermylen Thrombosis Research 26 (6), 389-400, 1982 | 189 | 1982 |
| Pharmacokinetics and pharmacodynamics of MK‐383, a selective non‐peptide platelet glycoprotein‐IIb/IIIa receptor antagonist, in healthy men JS Barrett, G Murphy, K Peerlinck, ID Lepeleire, RJ Gould, D Panebianco, ... Clinical Pharmacology & Therapeutics 56 (4), 377-388, 1994 | 185 | 1994 |
| Dipyridamole inhibits platelet aggregation in whole blood P Gresele, C Zoja, H Deckmyn, J Arnout, J Vermylen, M Verstraete Thrombosis and haemostasis 50 (08), 852-856, 1983 | 185 | 1983 |
| Shielding of the A1 domain by the D′ D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V H Ulrichts, M Udvardy, PJ Lenting, I Pareyn, N Vandeputte, ... Journal of Biological Chemistry 281 (8), 4699-4707, 2006 | 178 | 2006 |
| ADAMTS13-mediated thrombolysis of t-PA–resistant occlusions in ischemic stroke in mice F Denorme, F Langhauser, L Desender, A Vandenbulcke, H Rottensteiner, ... Blood, The Journal of the American Society of Hematology 127 (19), 2337-2345, 2016 | 170 | 2016 |
Hendrik B. FeysPrincipal Investigator Transfusion Research Center在 rodekruis.be 的电子邮件经过验证
